Shuyu Liu

发表

Identification and anti-tumor evaluation of 3-acyl-indol-based 2,4-diarylaminopyrimidine analogues as potent ALK inhibitors capable of overcoming drug-resistant mutants.

X. Zhai, Nan Jiang, Ming-juan Guo, 2022, European journal of medicinal chemistry.

Differential effects of angiotensin II receptor blockers on A (cid:2) generation

K. Zou, H. Komano, Tomoji Maeda, 2015 .

ATP increases the migration of microglia across the brain endothelial cell monolayer

H. Komano, Tomoji Maeda, K. Zou, 2016, Bioscience reports.

Design, synthesis and antitumor evaluation of ATP dual-mimic 2,4-diarylaminopyrimidine and aminoindazole conjugates as potent anaplastic lymphoma kinase inhibitors.

X. Zhai, Jing Yang, Jiahao Zhang, 2022, European journal of medicinal chemistry.

Aβ42-to-Aβ40- and Angiotensin-converting Activities in Different Domains of Angiotensin-converting Enzyme*

K. Zou, M. Michikawa, Y. Satoh, 2009, The Journal of Biological Chemistry.

Fragment-based discovery of novel phenyltriazolyl derivatives as allosteric type-I1/2ALK inhibitors with promising antitumor effects.

X. Zhai, Nan Jiang, B. Shao, 2022, Bioorganic & medicinal chemistry letters.

An E3 Ubiquitin Ligase, Synoviolin, Is Involved in the Degradation of Homocysteine-Inducible Endoplasmic Reticulum Protein.

K. Zou, T. Nakajima, H. Komano, 2018, Biological & pharmaceutical bulletin.

Conversion of Aβ43 to Aβ40 by the successive action of angiotensin‐converting enzyme 2 and angiotensin‐converting enzyme

K. Zou, A. Turner, Y. Terayama, 2014, Journal of neuroscience research.

A clinical dose of angiotensin-converting enzyme (ACE) inhibitor and heterozygous ACE deletion exacerbate Alzheimer's disease pathology in mice

K. Zou, M. Michikawa, F. Ando, 2019, The Journal of Biological Chemistry.

Angiotensin type 1a receptor deficiency decreases amyloid β-protein generation and ameliorates brain amyloid pathology

K. Zou, M. Michikawa, H. Komano, 2015, Scientific Reports.

Differential effects of angiotensin II receptor blockers on Aβ generation

Shuyu Liu, K. Zou, H. Komano, 2014, Neuroscience Letters.

Aβ43 is the earliest-depositing Aβ species in APP transgenic mouse brain and is converted to Aβ41 by two active domains of ACE.

K. Zou, Satoshi Takahashi, M. Michikawa, 2013, The American journal of pathology.

Exogenous administration of mitochondrial DNA promotes ischemia reperfusion injury via TLR9‐p38 MAPK pathway

Lijun Wang, Jing Liu, Jianbin Gong, 2017, Regulatory toxicology and pharmacology : RTP.

NAD(P)H quinone oxidoreductase 1 inhibits the proteasomal degradation of homocysteine-induced endoplasmic reticulum protein.

K. Zou, T. Nakajima, Chihiro Abe, 2016, Biochemical and biophysical research communications.

The Ubiquitin Ligase Synoviolin Up-regulates Amyloid β Production by Targeting a Negative Regulator of γ-Secretase, Rer1, for Degradation*

K. Zou, T. Nakajima, H. Komano, 2012, The Journal of Biological Chemistry.

Differential Appearance of Serum Aβ43 and Aβ42 in the Patients with Alzheimer's Disease

K. Zou, Satoshi Takahashi, Y. Terayama, 2011 .

Iron treatment inhibits Aβ42 deposition in vivo and reduces Aβ42/Aβ40 ratio.

K. Zou, M. Michikawa, K. Sera, 2019, Biochemical and biophysical research communications.

The Ubiquitin Ligase Synoviolin Up-regulates Amyloid β Production by Targeting a Negative Regulator of γ-Secretase, Rer1, for Degradation*

K. Zou, T. Nakajima, H. Komano, 2012, The Journal of Biological Chemistry.